Mononuclear and polymorphonuclear leukocytes show increased fructose-1,6-bisphosphatase activity in patients with type 1 diabetes mellitus

Cell Biology International

Volumn 30, Issue 7, 2006, Pages 624-630

  Sybirna, Natalia ^a   Dziewulska Szwajkowska, Daria ^b   Barska, Marina ^a   Dzugaj, Andrzej ^b  

^a IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Diabetes mellitus type 1; Fructose 1,6 bisphosphatase; Mononuclear cells; Polymorphonuclear cells

Indexed keywords

FRUCTOSE BISPHOSPHATASE;

ADULT; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOLYSIS; CYTOPLASM; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROSCOPY; MONONUCLEAR CELL; NEUTROPHIL;

ADULT; CELL NUCLEUS; CYTOPLASM; DIABETES MELLITUS, TYPE 1; FEMALE; FRUCTOSE-BISPHOSPHATASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUTROPHILS;

EID: 33746299521     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.03.008     Document Type: Article

References (36)

1. Akesson B., Panagiotidis G., Westermark P., and Lundquist I. Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. Regul Pept 2003 111 (2003) 55-60
2. Bajaj M., and Defronzo R.A. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 10 (2003) 311-323
3. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 (1996) 1424-1437
4. Benkovic S.J., and De Maine M.M. Mechanism of action of fructose 1,6-bisphosphatase. Adv Enzymol Relat Areas Mol Biol 53 (1982) 45-82
5. Boyum A. Isolation of leukocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 97 (1968) 9-29
6. Dinneen S., Alzaid A., Turk D., and Rizza R. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38 (1995) 337-343
7. Dzugaj A., and Kochman M. Purification of human liver fructose-1,6-bisphosphatase. Biochim Biophys Acta 614 (1980) 407-412
8. Gerich J.E., Langlois M., Noacco C., Lorenzi M., Karam J.H., and Korsham P.H. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. J Clin Invest 58 (1976) 320-325
9. Gizak A., and Dzugaj A. FBPase is in the nuclei of cardiomyocytes. FEBS Lett 539 (2003) 51-55
10. Gizak A., Rakus D., Kolodziej J., Zabel M., Ogorzalek A., and Dzugaj A. Human lung fructose-1,6-bisphosphatase is localized in pneumocytes II. Histol Histopathol 16 (2001) 53-55
11. Gizak A., Rakus D., and Dzugaj A. Immunohistochemical localization of human fructose-1,6-bisphosphatase in subcellular structures of myocytes. Histol Histopathol 18 (2003) 135-142
12. Haluzik M., and Nedvidkova J. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiol Res 49 Suppl 1 (2000) 37-42
13. Jiang G., and Zhang B.B. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284 (2003) E671-E678
14. Kelly D.J., Gilbert R.E., and Cox A.J. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 12 (2001) 2098-2107
15. Kelly M.A., Mijovic C.H., and Barnett A.H. Genetics of type 1 diabetes. Best Pract Res Clin Endocrinol Metab 15 (2001) 279-291
16. Kikawa Y., Inuzuka M., Takano T., Shigematsu Y., Nakai A., Yamamoto Y., et al. cDNA sequences encoding human fructose 1,6-bisphosphatase from monocytes, liver and kidney: application of monocytes to molecular analysis of human fructose1,6-bisphosphatase deficiency. Biochem Biophys Res Commun 199 (1994) 687-693
17. Klover P.J., and Mooney R.A. Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol. 36 (2004) 753-758
18. Knapik-Kordecka M., Piwowar A., and Warwas M. Contents of glycogen in neutrophils in patients with diabetes. Pol Arch Med Wewn 96 (1996) 435-441
19. Lager I. The insulin-antagonistic effect of the counterregulatory hormones. J Intern Med 735 (1991) 41-47
20. Lawrence G.M., Jepson M.A., Trayer I.P., and Walker D.G. The compartmentation of glycolytic and gluconeogenic enzymes in rat kidney and liver and its significance to renal and hepatic metabolism. Histochem J 1 (1986) 45-53
21. Ludvik B., Thomaseth K., Nolan J.J., Clodi M., Prager R., and Pacini G. Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest 33 (2003) 316-322
22. Okar D.A., Wu C., and Lange A.J. Regulation of the regulatory enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Adv Enzyme Regul 44 (2004) 123-154
23. Pehling G., Tessari P., Gerich J.E., Haymond M.W., Service F.J., and Rizza R.A. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 74 (1984) 985-991
24. Pratt W.K. Digital image processing (2001), John Wiley, New York 735 pp.
25. Pilkis S.J., and Claus T.H. Hepatic gluconeogenesis/glycolysis: regulation and structure/ function relationship of substrate cycle enzymes. Annu Rev Nutr 11 (1991) 465-515
26. Quinn P.G., and Yeagley D. Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 423-437
27. Rakus D., Pasek M., Krotkiewski H., and Dzugaj A. Interaction between muscle aldolase and muscle fructose-1,6-bisphosphatase results in the substrate channeling. Biochemistry 43 (2004) 14948-14957
28. Roden M., and Bernroider E. Hepatic glucose metabolism in humans-its role in health and disease. Best Pract Res Clin Endocrinol Metab 17 (2003) 365-383
29. Segers O., Somers G., Sener A., and Malaisse W.J. Blood glycogen and metabolic control in diabetes mellitus. Diabetes Med 7 (1990) 207-210
30. Skalecki K., Rakus D., Wisniewski J.R., Kolodziej J., and Dzugaj A. cDNA sequence and kinetic properties of human lung fructose(1, 6)bisphosphatase. Arch Biochem Biophys 365 (1999) 1-9
31. Sybirna N.O. Molecular mechanisms of regulation of morphological and functional state of platelets in the type 1 diabetes mellitus. Lab Diagn 1 (2004) 9-16
32. Tejwani G.A. Regulation of fructose-bisphosphatase activity. Adv Enzymol Relat Areas Mol Biol 54 (1983) 121-194
33. Tillmann H., Bernhard D., and Eschrich K. Fructose-1,6-bisphosphatase genes in animals. Gene 291 (2002) 57-66
34. Wu C., Khan S.A., and Lange A.J. Regulation of glycolysis-role of insulin. Exp Gerontol 40 (2005) 894-899
35. Yanez A.J., Bertinat R., Concha I.I., and Slebe J.C. Nuclear localization of liver FBPase isoenzyme in kidney and liver. FEBS Lett 550 (2003) 35-40
36. Zmojdzian M., Dziewulska-Szwajkowska D., and Dzugaj A. Localization of chicken muscle FBPase in cardiomyocyte nuclei. Comp Biochem Physiol B 140 (2005) 37-43